Per- and Poly-fluoroalkyl Substances (PFAS) in Circulation in a Canadian Population: Their Association with Serum Liver Enzyme Biomarkers and Piloting a Novel Method to Reduce Serum PFAS
View ORCID ProfileJennifer J. Schlezinger, View ORCID ProfileAnila Bello, View ORCID ProfileKelsey M. Mangano, View ORCID ProfileKushal Biswas, Paridhiben P. Patel, View ORCID ProfileEmily H. Pennoyer, View ORCID ProfileThomas M.S. Wolever, View ORCID ProfileWendy J. Heiger-Bernays, View ORCID ProfileDhimiter Bello
doi: https://doi.org/10.1101/2024.08.02.24311171
Jennifer J. Schlezinger
1Department of Environmental Health, Boston University, Boston, Massachusetts, USA
Anila Bello
2Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts, Lowell, Massachusetts, USA
Kelsey M. Mangano
3Department of Biomedical and Nutritional Sciences, Zuckerberg College of Health Sciences, University of Massachusetts, Lowell, Massachusetts, USA
Kushal Biswas
3Department of Biomedical and Nutritional Sciences, Zuckerberg College of Health Sciences, University of Massachusetts, Lowell, Massachusetts, USA
Paridhiben P. Patel
3Department of Biomedical and Nutritional Sciences, Zuckerberg College of Health Sciences, University of Massachusetts, Lowell, Massachusetts, USA
Emily H. Pennoyer
1Department of Environmental Health, Boston University, Boston, Massachusetts, USA
Thomas M.S. Wolever
4INQUIS Clinical Research, Ltd. (formerly GI Labs), Toronto, Ontario, Canada
Wendy J. Heiger-Bernays
1Department of Environmental Health, Boston University, Boston, Massachusetts, USA
2Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts, Lowell, Massachusetts, USA
Dhimiter Bello
3Department of Biomedical and Nutritional Sciences, Zuckerberg College of Health Sciences, University of Massachusetts, Lowell, Massachusetts, USA
Posted August 03, 2024.
Per- and Poly-fluoroalkyl Substances (PFAS) in Circulation in a Canadian Population: Their Association with Serum Liver Enzyme Biomarkers and Piloting a Novel Method to Reduce Serum PFAS
Jennifer J. Schlezinger, Anila Bello, Kelsey M. Mangano, Kushal Biswas, Paridhiben P. Patel, Emily H. Pennoyer, Thomas M.S. Wolever, Wendy J. Heiger-Bernays, Dhimiter Bello
medRxiv 2024.08.02.24311171; doi: https://doi.org/10.1101/2024.08.02.24311171
Per- and Poly-fluoroalkyl Substances (PFAS) in Circulation in a Canadian Population: Their Association with Serum Liver Enzyme Biomarkers and Piloting a Novel Method to Reduce Serum PFAS
Jennifer J. Schlezinger, Anila Bello, Kelsey M. Mangano, Kushal Biswas, Paridhiben P. Patel, Emily H. Pennoyer, Thomas M.S. Wolever, Wendy J. Heiger-Bernays, Dhimiter Bello
medRxiv 2024.08.02.24311171; doi: https://doi.org/10.1101/2024.08.02.24311171
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (210)
- Cardiovascular Medicine (2995)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12891)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4684)
- Geriatric Medicine (431)
- Health Economics (738)
- Health Informatics (2980)
- Health Policy (1081)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (437)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4474)
- Nursing (239)
- Nutrition (656)
- Oncology (2322)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1212)
- Primary Care Research (509)
- Public and Global Health (7060)
- Radiology and Imaging (1570)
- Respiratory Medicine (930)
- Rheumatology (449)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (61)
- Transplantation (214)
- Urology (186)